Reports Outline Managed Care Study Results from University of Rochester (Fertility Care for All: Impact of New York State’s Medicaid Expansion On Infertility Care): Managed Care

2024 JAN 03 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Investigators publish new report on Managed Care. According to news reporting originating in Rochester, New York, by NewsRx journalists, research stated, “To assess whether the New York State (NYS) mandate expanding Medicaid coverage of fertility diagnostic testing and treatment is successfully increasing patient access to and utilization of fertility care.Methods A retrospective chart review was performed of NYS Medicaid patients who presented for fertility services to a large academic reproductive endocrinology and infertility (REI) clinic. Information on patient demographics, medical history, diagnostic testing, treatments, and outcomes was collected.”

The news reporters obtained a quote from the research from the University of Rochester, “Patients presenting to the clinic in the 1 year prior to the mandate (October 1, 2018-September 30, 2019) were compared to patients presenting in the 1 year after the mandate (October 1, 2019-September 30, 2020). Primary outcomes of the study were differences in presentation to the clinic between the two cohorts and differences in utilization of infertility diagnostic testing and treatment. Secondary outcomes were differences in treatment outcomes.Results A significantly larger percentage of Medicaid patients presented to the clinic for fertility assessment post-mandate (22%) as compared to pre-mandate (9%, p< 0.05). There were no demographic differences between the pre- and post-mandate patient groups. A similar percentage of patients completed diagnostic testing pre- vs. post-mandate. Post-mandate patients underwent more treatment cycles with ovulation induction medications compared to natural treatment cycles. There was no significant difference in pregnancy rates pre- vs. post-mandate.Conclusion The NYS Medicaid mandate allowed a significantly larger percentage of Medicaid patients to present for fertility evaluation.”

According to the news reporters, the research concluded: “The patients in the post-mandate cohort underwent more treatment cycles with ovulation induction medications compared to natural cycles.”

This research has been peer-reviewed.

For more information on this research see: Fertility Care for All: Impact of New York State’s Medicaid Expansion On Infertility Care. Journal of Assisted Reproduction and Genetics, 2023. Journal of Assisted Reproduction and Genetics can be contacted at: Springer|plenum Publishers, 233 Spring St, New York, NY 10013, USA. (Springer - www.springer.com; Journal of Assisted Reproduction and Genetics - http://www.springerlink.com/content/1058-0468/)

Our news correspondents report that additional information may be obtained by contacting Michelle Vu, University of Rochester, Dept. of Obstetrics and Gynecology, Med Ctr, 601 Elmwood Ave, Box 668, Rochester, NY 14642, United States. Additional authors for this research include Dana Stuehling, Dongmei Li and Snigdha Alur-Gupta.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s10815-023-02979-6. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)